Literature DB >> 2344614

Kinase activity controls the sorting of the epidermal growth factor receptor within the multivesicular body.

S Felder1, K Miller, G Moehren, A Ullrich, J Schlessinger, C R Hopkins.   

Abstract

We compared the internalization and intracellular sorting of epidermal growth factor receptor (EGF-R) and point mutant kinase-negative EGF-R separately expressed in NIH 3T3 cells lacking endogenous receptor. Both EGF-Rs internalized rapidly, but kinase-negative receptor was surface down-regulated only with monensin or at 20 degrees C. Furthermore, EGF internalized by mutant receptor alone was, in significant proportion, returned to the cell surface undegraded. Hence unlike wild-type receptor, kinase-negative EGF-R recycles. By electron microscopy the early pathways of endocytosis for the two receptors were identical; however, after 10-20 min the pathways diverged at the multivesicular body (MVB). Wild-type EGF-R, destined for degradation, localized to internal vesicles, while kinase-negative EGF-R, destined for recycling, localized to surface membranes of the MVBs and moved to small tubulovesicles. We conclude that sorting of internalized receptor for degradation or recycling can occur through spatial segregation within the MVB, and sorting of EGF-R is controlled by tyrosine kinase activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2344614     DOI: 10.1016/0092-8674(90)90474-s

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  120 in total

1.  Bilayered clathrin coats on endosomal vacuoles are involved in protein sorting toward lysosomes.

Authors:  Martin Sachse; Sylvie Urbé; Viola Oorschot; Ger J Strous; Judith Klumperman
Journal:  Mol Biol Cell       Date:  2002-04       Impact factor: 4.138

2.  Proteasome inhibitors block a late step in lysosomal transport of selected membrane but not soluble proteins.

Authors:  P van Kerkhof; C M Alves dos Santos; M Sachse; J Klumperman; G Bu; G J Strous
Journal:  Mol Biol Cell       Date:  2001-08       Impact factor: 4.138

3.  Cbl-directed monoubiquitination of CIN85 is involved in regulation of ligand-induced degradation of EGF receptors.

Authors:  Kaisa Haglund; Noriaki Shimokawa; Iwona Szymkiewicz; Ivan Dikic
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-06       Impact factor: 11.205

4.  Ent5p is required with Ent3p and Vps27p for ubiquitin-dependent protein sorting into the multivesicular body.

Authors:  Anne Eugster; Eve-Isabelle Pécheur; Fabrice Michel; Barbara Winsor; François Letourneur; Sylvie Friant
Journal:  Mol Biol Cell       Date:  2004-04-23       Impact factor: 4.138

5.  Substitution of C-terminus of VEGFR-2 with VEGFR-1 promotes VEGFR-1 activation and endothelial cell proliferation.

Authors:  Rosana D Meyer; Amrik Singh; Fredric Majnoun; Catharina Latz; Kameran Lashkari; Nader Rahimi
Journal:  Oncogene       Date:  2004-07-15       Impact factor: 9.867

6.  Disruption of the CD4-p56lck complex is required for rapid internalization of CD4.

Authors:  B P Sleckman; J Shin; V E Igras; T L Collins; J L Strominger; S J Burakoff
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

7.  Rab28 function in trypanosomes: interactions with retromer and ESCRT pathways.

Authors:  Jennifer H Lumb; Ka Fai Leung; Kelly N Dubois; Mark C Field
Journal:  J Cell Sci       Date:  2011-11-18       Impact factor: 5.285

Review 8.  Dynamics of ESCRT proteins.

Authors:  Nolwenn Jouvenet
Journal:  Cell Mol Life Sci       Date:  2012-06-06       Impact factor: 9.261

Review 9.  Multivesicular bodies in neurons: distribution, protein content, and trafficking functions.

Authors:  Christopher S Von Bartheld; Amy L Altick
Journal:  Prog Neurobiol       Date:  2011-01-07       Impact factor: 11.685

10.  STAM proteins bind ubiquitinated proteins on the early endosome via the VHS domain and ubiquitin-interacting motif.

Authors:  Emi Mizuno; Kensuke Kawahata; Masaki Kato; Naomi Kitamura; Masayuki Komada
Journal:  Mol Biol Cell       Date:  2003-06-13       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.